Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) (“Marapharm” or the “Company) announces that in preparation for the transition to the permanent facilities, cloning has begun from the championed mother plants.
During the past eight months, Mr. Keating, Director of Operations and Lead Cultivators Mr. Hunter and Mr. George, have used breeding techniques to select and establish our first mother plants, using award winning genetics. Pheno-Hunting, a rigorous screening process, required patience, analysis and persistence. The team pursued superior mother plants, which exhibited strong attributes and DNA characteristics to include; yield, potency, terpene and cannabinoid profiles, taste, aroma, plant structure and node placement.
These mother plants, which have been grown in our temporary facilities, are being used for the harvesting of clones. By cloning, you can create a new harvest with exact replicas of your best performing plants, genetically identical to the plant they were taken from.
Propagation of several thousand clones has begun from the mother plants of the top five strains chosen for the Nevada market, which recorded sales of $49.5 million in the month of March (provided by the State of Nevada Department of Taxation). These strains, highly valued for their properties include:
Lemon Skunk, mostly Sativa: A breed of two Skunks with specially chosen phenotypes selected for their lemon characteristics. One is from Holland the other from Las Vegas. Fragrant buds which are light green with thick orange hairs.
Moonshine Ghost Train, mostly Sativa: A mix of the Cannabis cup winning Moonshine Haze and the “2x Strongest strain on earth “Ghost Train Haze #1. It has a classic haze flavour strain with a lemon overtone and a tropical fuel finish.
Honey Banana, mostly Indica: Genetically composed by Honey Boo crossed with Strawberry Bananas, Honey Bananas develop big dense crystallized honey buds. Honey Bananas has a sweet banana aroma and flavour, the effect is strong and powerful.
Kosher Kush, mostly Indica: Won 1st place, Seattle Cannabis Cup, in 2014 and won Cannabis Cup in 2011. This amazing strain from California has a strong smell with distinctive earthy tones and unleaded gas aroma.
B.F. Blue Cheese, mostly Indica: Intense and pungent aged-cheese aromas are tempered with sweet blueberry notes and develop tight, sticky colas – the effect is both potent, calming and relaxing.
“After years of working with seeds from some of the worlds top breeders, we are very excited about our current “moms”. Our most recent pheno-farming effort here in Nevada has produced some of the most vibrant and healthy “moms” we have seen as cultivators in many years!” Kurt Keating, Director of Operations.
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production or dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
FOR FURTHER INFORMATION:
Linda Sampson, CEO
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm’s ability to access private and public capital could be affected and or could not be available to support continuing operations. Marapharm’s business is conducted in a manner consistent with state law and is in compliance with licensing requirements.
Copies of licenses are posted on Marapharm’s website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US.
FORWARD – LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, ‘may”, “will”, “project”, “should”, ‘believe”, and similar expressions are intended to identify forward- looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward- looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.